Literature DB >> 25355138

Function of α-synuclein and PINK1 in Lewy body dementia (Review).

Akari Minami1, Atsuko Nakanishi1, Satoru Matsuda1, Yasuko Kitagishi1, Yasunori Ogura1.   

Abstract

α-Synuclein (α-syn) is the major protein component of Lewy bodies, a key pathological characteristic of the degenerating brain. The misfolding and aggregation of α-syn is associated with both the idiopathic and familial forms of Parkinson's disease (PD) and Lewy body dementia (LBD). However, the function of α-syn is poorly understood, as it shows both neurotoxic and neuroprotective activities. Mutations in phosphatase and tensin homologue-induced putative kinase 1 (PINK1) also cause recessively inherited PD. Studies support the notion of neuroprotective roles for PINK1, as it protects cells from damage-induced mitochondrial dysfunction, oxidative stress and cell apoptosis. PINK1 plays an essential role in mitochondrial quality control and its homeostasis is maintained through mitochondrial stabilization. The α-syn aggregation is linked to various aspects of mitochondrial dysfunction and PINK1-related mitophagy. Determination of the molecular pathways that lead to α-syn oligomerization and further aggregation may be the basis for the successful design and development of treatments for these neurodegenerative diseases. The present review summarizes the function of PINK1 underlying α-syn aggregation and the mechanisms through which mitochondrial dysfunction plays a role in this process.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25355138     DOI: 10.3892/ijmm.2014.1980

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

Review 1.  The delta-opioid receptor and Parkinson's disease.

Authors:  Jin-Zhong Huang; Yi Ren; Yuan Xu; Tao Chen; Terry C Xia; Zhuo-Ri Li; Jian-Nong Zhao; Fei Hua; Shi-Ying Sheng; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2018-08-03       Impact factor: 5.243

Review 2.  Psychosis in parkinsonism: an unorthodox approach.

Authors:  Marco Onofrj; Danilo Carrozzino; Aurelio D'Amico; Roberta Di Giacomo; Stefano Delli Pizzi; Astrid Thomas; Valeria Onofrj; John-Paul Taylor; Laura Bonanni
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-16       Impact factor: 2.570

3.  Dysregulation of Human Somatic piRNA Expression in Parkinson's Disease Subtypes and Stages.

Authors:  Tianjiao Zhang; Garry Wong
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

4.  Cytoprotection against Hypoxic and/or MPP⁺ Injury: Effect of δ-Opioid Receptor Activation on Caspase 3.

Authors:  Yuan Xu; Feng Zhi; Naiyuan Shao; Rong Wang; Yilin Yang; Ying Xia
Journal:  Int J Mol Sci       Date:  2016-08-09       Impact factor: 5.923

5.  PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation.

Authors:  Weiwei Yang; Xue Wang; Jia Liu; Chunli Duan; Ge Gao; Lingling Lu; Shun Yu; Hui Yang
Journal:  Oncotarget       Date:  2017-10-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.